Rosa Marina Melillo

机构：Federico II University Hospital, University of Naples Federico II · ORCID：0000-0002-9233-5275

发表论文 206 篇 · 总被引 9443 次 · h-index 55

代表论文

• In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies (2022 · Journal for ImmunoTherapy of Cancer · 被引 65)
• Probiotic Lactobacillus rhamnosus GG ( LGG ) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1 (2022 · Molecular Oncology · 被引 29)
• The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression (2022 · Cancers · 被引 24)
• Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines (2022 · Cancers · 被引 18)
• The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma (2022 · Journal of Experimental & Clinical Cancer Research · 被引 16)
• Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer (2021 · Cancers · 被引 15)